Dunn M J, Burghes A H, Dubowitz V
Biochem J. 1982 Mar 1;201(3):445-53. doi: 10.1042/bj2010445.
The Ca2+-stimulated Mg2-dependent ATPase activities (Ca2+-ATPase) of erythrocyte-ghost membranes from patients with Duchenne muscular dystrophy (DMD) and carriers of DMD were compared with activities of normal controls. The Ca2+-ATPase activity of DMD-patient ghost preparations was found to follow the same pattern of activation by Ca2+ as the control membranes. However, the Ca2+-ATPase activity in DMD and some DMD-carrier preparations was substantially elevated compared with controls. To characterize further the elevated Ca2+-ATPase activity found in DMD-patient ghost membrane preparations, we estimated kinetic parameters using both fine adjustment and weighting methods to analyse our experimental data. It was established that in both DMD and DMD-carrier preparations the increase in Ca2+-ATPase activity was reflected by a significant increase in Vmax. rather than by any change in Km. The response of the membrane Ca2+-ATPase activity to changes in temperature was also investigated. In all preparations a break in the Arrhenius plot occurred at 20 degrees C, and in DMD and DMD-carrier preparations an elevated Ca2+-ATPase activity was detected at all temperatures. Above 20 degrees C the activation energy for all types of preparation was the same, whereas below this temperature there appeared to be an elevated activation in DMD and DMD-carrier preparations compared with normal controls. The concept that a generalized alteration in the physicochemical nature of the membrane lipid domain may be responsible for the many abnormal membrane properties reported in DMD is discussed.
将杜兴氏肌营养不良症(DMD)患者及DMD携带者红细胞膜的钙离子刺激的镁离子依赖性ATP酶活性(Ca2+-ATP酶)与正常对照者的活性进行了比较。发现DMD患者红细胞膜制剂的Ca2+-ATP酶活性与对照膜一样遵循相同的钙离子激活模式。然而,与对照组相比,DMD患者及一些DMD携带者制剂中的Ca2+-ATP酶活性显著升高。为了进一步表征在DMD患者红细胞膜制剂中发现的升高的Ca2+-ATP酶活性,我们使用精细调节和加权方法估计动力学参数以分析我们的实验数据。已确定在DMD和DMD携带者制剂中,Ca2+-ATP酶活性的增加反映为Vmax的显著增加,而不是Km的任何变化。还研究了膜Ca2+-ATP酶活性对温度变化的反应。在所有制剂中,阿累尼乌斯图在20℃出现转折,并且在DMD和DMD携带者制剂中在所有温度下均检测到升高的Ca2+-ATP酶活性。在20℃以上,所有类型制剂的活化能相同,而在此温度以下,与正常对照相比,DMD和DMD携带者制剂中似乎存在升高的活化作用。讨论了膜脂域物理化学性质的普遍改变可能是DMD中报道的许多异常膜特性的原因这一概念。